Alimentary pharmacology
22 flashcards · Other · by Anonymous Sloth
What are the main classes of drugs used in the treatment of alimentary disease
Acid suppression Antacids H2-receptor antagonist Proton pump inhibitor Drugs affecting GI motility Anti-emetics Anti-muscarinics Anti-motility IBD drugs Aminosalicylates Corticosteroids Immunosuppressants Biologics Intestinal secretion drugs bile acid sequestrates Ursodeoxycholic acid
Mechanism, indication, contraindication of antacids
Contain magnesium or aluminium Neutralise acid Taken to suppress symptoms
Mechanism, indication, contraindication of alginates
Form thick gel layer on stomach content Prevent further reflux E.g Gaviscon
Mechanism, indication, contraindication of H2 receptor antagonists
Bind and block the histamine receptor in the parietal cell Prevents further acid secretion Indicated for GORD and peptic ulcer disease IV or oral route
Mechanism, indication, contraindication of proton pump inhibitors
Block the proton pump Reduces acid secretion Indicated for GORD and peptic ulcer disease Given orally or IV
Mechanism, indication, contraindication of prokinetic agents
Increase gut motility and gastric emptying Unclear mechanism however involves parasympathetic control of the smooth muscle and sphincter tone. Used in Gastroparesis GORD Anti-emetics
Mechanism, indication, contraindication of GI motility inhibitory agents
Decrease the release of acetylcholine in the opiate receptors of the GI tract Decreases smooth muscle contraction and increases anal sphincter tone
Mechanism, indication, contraindication of anti-spasmodic agents
Reduce symptoms of IBS and renal colic (stones) Mechanism anti-cholinergic muscarinic antagonists (inhibit smooth muscle constriction in gut wall) Peppermint calcium-channel blocker Decreases muscle contraction
What are the four types of laxatives
Bulk Osmotic Stimulant Softeners All work by increasing bulk or drawling fluid into the gut
Issue associated with laxatives
Obstruction Oral or rectal administration Osmotic laxatives do not work without adequate fluid intake Misuse (eating disorder)
Mechanism, indication, contraindication of aminosalicylates
Unclear mechanism but performs as an anti-inflammatory Oral or rectal administration Contraindication for renal impairment Adverse reaction GI upset blood upset Renal impairment
Mechanism, indication, contraindication of Corticosteroids
Anti-inflammatory Oral, IV or rectal Contraindication osteoporosis Cushings disorder Infection susceptibility
Mechanism, indication, contraindication of immunosuppressants
Prevent purine formation in DNA synthesis (reduces immune cell growth) Adverse reaction bone marrow suppression organ damage Drug interaction
Mechanism, indication, contraindication of biologics
Prevents action of TNF -alpha antibodies Used for psoriasis and rheumatoid arthritis Addresses inflammatory response but not the underlying disease Contraindication TB infection MS Pregnancy/ breastfeeding Adverse reaction Infection risk Infusion reaction (pruritus, fever Anaemia, thrombocytopenia, neutropenia Malignancy
Mechanism, indication, contraindication of cholestyramine
Reduces bile salt reabsorption by bind and forming an insoluble complex Affects fat soluble vitamin absorption (decrease vitamin k levels)
Mechanism, indication, contraindication of ursodeoxycholic acid
Inhibition of enzyme involved in cholesterol formation Dissolves non-calcified stones Treatment of gallstones and primary biliary cirrhosis
How does the GI system affect drug pharmacokinetics
Alimentary system is directly in drug pharmacokinetics, diseases in the system can affect drug processing. Route of administration must be altered in the presence of GI symptoms
Describe the problems of pharmacokinetics (ADME) in the alimentary system
Absorption is dependent on pH Gut length Transit time Distribution Low albumin (decreased binding of fat soluble drugs and increased free drug concentration) Metabolism Liver enzymes ( variability directly affects drug toxicity) Increased gut flora cause increased metabolism Reduced first pass metabolism Hepatic portal blood flow Excretion Accummulation of toxins in hepatic-biliary disease Spironolactone
Common GI adverse effects
GI upset Diarrhoea/ constipation 25% drug-induced diarrhoea due to antimicrobials Acute or chronic GI bleeding/ ulceration Low dose acorn/ NSAIDS Warfarin NOAC Due to higher bleeding tendency and ulcer causation Changes to gut flora Antibiotics Reduced vitamin K absorption (increased clotting time) Overgrowth of pathogenic bacteria
Describe drug induced liver injury
Principles of prescribing for patients with liver disease
Care and avoidance of: Drugs that become toxic due to changes in pharmacokinetics (liver metabolism, therapeutic index, biliary excretion) Drugs with hepatotoxicity Drugs that worsen non-liver factors of liver disease (encephalopathy)
What drugs in particular worsen liver disease
Particular drugs Warfarin/ anti-coagulants (liver produces less clotting factors) Aspirin/ NSAIDS (increases prothrombin time and worsens ascites( Opiates/ benzodiazepines (can cause encephalopathy by increasing sedation)